Highly purified human alpha-thrombin promotes morphological transformation of BALB/c 3T3 cells.
Purified human alpha-thrombin stimulates phosphoinositide turnover as a necessary step in its stimulation of fibroblast cell proliferation. Since phosphoinositide turnover releases diacylglycerol, which activates protein kinase C, we postulated that long-term exposure to thrombin might promote cellular transformation in a manner similar to long-term exposure to phorbol esters, which also activate protein kinase C. The present studies show that chronic exposure of BALB/c 3T3 cells (subclone A31-1-13) to thrombin (5 micrograms/ml) led to a 4- to 20-fold increase in the frequency of morphological transformation over controls as determined by induced foci in monolayer cultures. The foci appeared to represent true transformants as cells from randomly selected foci grew in soft agar and had saturation densities 2- to 3-fold higher than control cells. Acute thrombin treatment for 24 h resulted in small but statistically significant (P less than 0.05) increases in morphological transformation with or without promotion by phorbol myristate acetate, indicating that thrombin can act as a weak initiator or complete carcinogen in this test system. Initiation of cells with low levels of 3-methylcholanthrene followed by promotion with thrombin caused a greater enhancement of morphological transformation (P less than 0.005). Thus, it appears that most of the stimulation of in vitro cell transformation by thrombin may be due to its promotional activity. These results raise the possibility that thrombin released locally following tissue injury or chronic irritation may play a role in cellular transformation and tumor development, especially in tissues sensitized by exposure to initiating carcinogens.
Morris
D L
DL
Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston 77550.
Ward
J B
JB
Nechay
P
P
Whorton
E B
EB
Fenton
J W
JW
Carney
D H
DH
D016475:3T3 Cells / Q000187:drug effects; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D004815:Epidermal Growth Factor / Q000494:pharmacology; D051379:Mice; D013755:Tetradecanoylphorbol Acetate; D013917:Thrombin / Q000494:pharmacology*
D004815:Epidermal Growth Factor; D013917:Thrombin; D013755:Tetradecanoylphorbol Acetate